Sphingolipid metabolism and regulated cell death in malignant melanoma
Apoptosis · 2024
DOI: 10.1007/s10495-024-02002-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Apoptosis, 2024. Verfasst von Kexin Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China. Hauptthemen laut MEDLINE: Melanoma, Sphingolipids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 211 Literaturangaben. Gefördert von: Natural Science Foundation of Xizang Autonomous Region, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China. songhao199005@163.com.
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China. xxlqjl@sina.com.
Förderung
- Natural Science Foundation of Xizang Autonomous Region
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Yan, K., Zhang, W., Song, H., & Xu, X. (2024). Sphingolipid metabolism and regulated cell death in malignant melanoma. Apoptosis. https://doi.org/10.1007/s10495-024-02002-y
Vancouver
Yan K, Zhang W, Song H, Xu X. Sphingolipid metabolism and regulated cell death in malignant melanoma. Apoptosis. 2024. doi:10.1007/s10495-024-02002-y
BibTeX
@article{Yan2024,
author = {Yan, Kexin and Zhang, Wei and Song, Hao and Xu, Xiulian},
title = {Sphingolipid metabolism and regulated cell death in malignant melanoma},
journal = {Apoptosis},
year = {2024},
doi = {10.1007/s10495-024-02002-y}
}
EUVIMED